Atlas Trials

Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)

Clinical trial NCT00916942 · COMPLETED

Trial details

NCT number
NCT00916942
Sponsor
NeurogesX
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Postherpetic Neuralgia
Start date
2009-06-01
Primary completion
2009-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.